Home  »  Stock   »  Market data suggests positive returns on Clovis On...

Market data suggests positive returns on Clovis Oncology Inc. (CLVS)

Clovis Oncology Inc. (CLVS) is priced at $0.33 after the most recent trading session. At the very opening of the session, the stock price was $0.34 and reached a high price of $0.36, prior to closing the session it reached the value of $0.35. The stock touched a low price of $0.33.Recently in News on October 27, 2022, Clovis Oncology Presents Data from TRITON3 Phase 3 Trial of Rubraca® (rucaparib) at the 29th Annual Prostate Cancer Foundation Scientific Retreat. Clovis Oncology, Inc. (NASDAQ: CLVS) today announced the presentation of data from the TRITON3 Phase 3 trial in men with metastatic castration-resistant prostate cancer with BRCA or ATM mutations. The presentation titled, “TRITON3: A Phase 3 Study of Rucaparib vs. Physician’s Choice of Therapy in mCRPC Associated with Homologous Recombination Deficiency (HRD)” is being presented by Alan H. Bryce, MD, chair of the Division of Hematology and Medical Oncology at the Mayo Clinic and co-principal investigator of the TRITON3 trial during the session titled, “Novel Clinical Trial Updates” at the 29th Annual Prostate Cancer Foundation (PCF) Scientific Retreat. You can read further details here

Clovis Oncology Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.2500 on 07/08/22, with the lowest value was $0.2270 for the same time period, recorded on 11/09/22.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


Clovis Oncology Inc. (CLVS) full year performance was -89.35%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Clovis Oncology Inc. shares are logging -90.26% during the 52-week period from high price, and 46.39% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.23 and $3.41.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1642873 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Clovis Oncology Inc. (CLVS) recorded performance in the market was -87.74%, having the revenues showcasing -73.42% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 46.94M, as it employees total of 413 workers.

Specialists analysis on Clovis Oncology Inc. (CLVS)

During the last month, 0 analysts gave the Clovis Oncology Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.2940, with a change in the price was noted -2.52. In a similar fashion, Clovis Oncology Inc. posted a movement of -88.34% for the period of last 100 days, recording 5,789,639 in trading volumes.

Trends and Technical analysis: Clovis Oncology Inc. (CLVS)

Raw Stochastic average of Clovis Oncology Inc. in the period of last 50 days is set at 8.34%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 11.79%. In the last 20 days, the company’s Stochastic %K was 13.10% and its Stochastic %D was recorded 13.20%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -87.74%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -47.26%, alongside a downfall of -89.35% for the period of the last 12 months. The shares increased approximately by -9.46% in the 7-day charts and went up by -68.05% in the period of the last 30 days. Common stock shares were lifted by -73.42% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts